Potential toxic effects of iron oxide nanoparticles in in vivo and in vitro experiments

Journal of Applied Toxicology

Volumn 32, Issue 6, 2012, Pages 446-453

  Szalay, Brigitta ^a,b   Tátrai, Erzsébet ^c   Nyíro, Gábor ^a   Vezér, Tünde ^b   Dura, Gyula ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c Central Military Hospital Budapest   (Hungary)

Author keywords

Bacterial reverse mutation assay; Iron(II,III) oxide nanoparticle (IONP); Lungs; Magnetite; MTT assay

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; IRON OXIDE; MAGNETITE NANOPARTICLE; NANOPARTICLE;

AMES TEST; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOTOXICITY; ESCHERICHIA COLI; EVALUATION; HISTOPATHOLOGY; HYPERTHERMIA; IN VITRO STUDY; IN VIVO STUDY; LONG TERM EXPOSURE; MALE; MAMMAL; MORPHOLOGY; MUTAGENICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SAFETY; SALMONELLA TYPHIMURIUM; VERO CELL;

ANIMALS; BIOTRANSFORMATION; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; DNA DAMAGE; ESCHERICHIA COLI; FERRIC COMPOUNDS; INHALATION EXPOSURE; INTUBATION, INTRATRACHEAL; LUNG; MALE; METAL NANOPARTICLES; MUTAGENICITY TESTS; MUTAGENS; MUTATION; ORGAN SIZE; PULMONARY FIBROSIS; RATS; RATS, WISTAR; RIBOSOMAL PROTEINS; SALMONELLA TYPHIMURIUM; VERO CELLS; WEIGHT GAIN;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MAMMALIA; RATTUS; RATTUS NORVEGICUS; SALMONELLA TYPHIMURIUM;

EID: 84860237913     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1779     Document Type: Article

References (40)

1. Ames BN, McCann J, Yamasaki E. 1975. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat. Res. 31: 347-364.
2. Aoki H, Otaka Y, Igarashi K, Takenaka A. 2002. Soy protein reduces paraquat-induced oxidative stress in rats. J. Nutr. 132: 2258-2262.
3. Balasubramanyam A, Sailaja N, Mahboob M, Rahman MF, Hussain SM, Grover P. 2010. In vitro mutagenicity assessment of aluminium oxide nanomaterials using the Salmonella/microsome assay. Toxicol. Vitro 24: 1871-1878.
4. Dave SR, Gao XH. 2009. Monodisperse magnetic nanoparticles for biodetection, imaging, and drug delivery: a versatile and evolving technology. Wiley Interdiscip Rev. Nanomed. Nanobiotechnol. 1: 583-609.
5. EC. 2004. COM 338. Communication from the Commission. Towards a European strategy for nanotechnology. Commission of the European Communities: Brussels, 12 May.
6. Fahmy B, Cormier SA. 2009. Copper oxide nanoparticles induce oxidative stress and cytotoxicity in airway epithelial cells. Toxicol. Vitro 23: 1365-1371.
7. Gould P. 2006. Nanomagnetism shows in vivo potential. Nanotoday 1: 34-39.
8. Gupta AK, Curtis ASG. 2004. Surface modified superparamagnetic nanoparticles for drug delivery: interaction studies with human fibroblasts in culture. J. Mater. Sci. Mater. Med. 15(4): 493-496.
9. Gupta AK, Naregalkar RR, Vaidya VD, Gupta M. 2007. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine 2: 23-39.
10. Horváth E, Oszlánczi G, Máthé Zs, Szabó A, Kozma G, Sápi A, Kónya Z, Paulik E, Nagymajtényi L, Papp A. 2011. Nervous system effects of dissolved and nanoparticulate cadmium in rats in subacute exposure. J. Appl. Toxicol. 31: 471-476.
11. Jarzyna PA, Skajaa T, Gianella A, Cormode DP, Samber DD, Dickson SD, Chen W, Griffioen AW, Fayad ZA, Mulder WJM. 2009. Iron oxide core oil-in-water emulsions as a multifunctional nanoparticle platform for tumor targeting and imaging. Biomaterials 30: 6947-6954.
12. 4 nanoparticles and chemotherapy agents interact synergistically to induce apoptosis in lymphoma cells. Int. J. Nanomed. 5: 999-1004.
13. 3) nanoparticle in mammalian cell lines. Mol. Cell. Toxicol. 5: 172-178.
14. Kirkland DJ. 1994. Statistical evaluation of mutagenicity test data: recommendations of the U.K. Environmental Mutagen Society. Environ. Hlth Perspect. Suppl. 102(1): 43-47.
15. Kumar A, Pandey AK, Singh SS, Shanker R, Dhawan A. 2011. Cellular uptake and mutagenic potential of metal oxide nanoparticles in bacterial cells. Chemosphere 83: 1124-1132.
16. 4 in anticancer drug carriers with target-orientation and sustained-release properties. Biomed. Mater. 2: 132-134.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951 Protein measurement with the Folin-Phenol reagents. J. Biol. Chem. 193: 265-275.
18. Maenosono S Suzuki T Saita S. 2007. Mutagenicity of water-soluble FePt nanoparticles in Ames test. J. Toxicol. Sci. 32: 575-579.
19. Mahmoudi M, Simchi A, Imani M, Shokrgozar MA, Milani AS, Häfeli UO, Stroeve P. 2010. A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles. Colloids Surf. B: Biointerfaces 75: 300-309.
20. Maron DM, Ames BN. 1983. Revised methods for the salmonella mutagenicity test. Mutat. Res. 113: 173-215.
21. Naqvi S, Samim M, Abdin MZ, Ahmed FJ, Maitra AN, Prashant CK, Dinda AK. 2010. Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress. Int. J. Nanomed. 5: 983-989.
22. OECD. 1997. Guideline for the Testing of Chemicals: Bacteria Reverse Mutation Test. Guideline 471. Organization for Economic Cooperation and Development.
23. Oszlánczi G, Horváth E, Szabó A, Horváth E, Sápi A, Kozma G, Kónya Z, Paulik E, Nagymajtényi L, Papp A. 2010. Subacute exposure of rats by metal oxide nanoparticles through the airways: general toxicity and neuro-functional effects. Acta Biol. Szegediensis 54(2): 165-170.
24. Pan X, Redding JE, Wiley PA, Wena L, McConnell JS, Zhang B 2010. Mutagenicity evaluation of metal oxide nanoparticles by the bacterial reverse mutation assay. Chemosphere 79: 113-116.
25. Parkes WR. 1982. Occupational lung disorders. In Inert Dusts. Butterworths: London; 113-133.
26. Rezin GT, Cardoso MR, Goncalves CL, Scaini G, Fraga DB, Riegel RE, Comim CM, Quevedo J, Streck EL. 2008. Inhibition of mitochondrial respiratory chain in brain of rats subjected to an experimental model of depression. Neurochem. Int. 53: 395-400.
27. RSRAE. 2004. Royal Society and Royal Academy of Engineering Report, Nanoscience and Nanotechnologies: Opportunities and Uncertainties. Available from:.
28. Sárközi L, Horváth E, Kónya Z, Kiricsi I, Szalay B, Vezér T, Papp A. 2009. Subacute intratracheal exposure of rats to manganese nanoparticles: behavioral, electrophysiological, and general toxicological effects. Inhal. Toxicol. 21(S1): 83-91.
29. Sayes CM, Reed KL, Warheit DB. 2007. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol. Sci. 97: 163-180.
30. Schärer K. 1977. The effect of chronic underfeeding on organ weights of rats. Toxicology 7: 45-56.
31. Schroeder U, Sommerfeld P, Ulrich S, Sabel BA. 1998. Nanoparticle technology for delivery of drugs across the blood-brain barrier. J. Pharm. Sci. 87: 1305-1307.
32. Singh N, Manshian B, Jenkins GJS, Griffiths SM, Williams PM, Maffeis TGG, Wright CJ, Doak SH, Maffeis TGG, Wright CJ, Doak SH. 2009. NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials. Biomaterials 30: 3891-3914.
33. Sonvico F, Mornet S, Vasseur S, Dubernet C, Jaillard D, Degrouard J, Hoebeke J, Duguet E, Colombo P, Couvreur P. 2005. Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments. Bioconjug. Chem. 16(5): 1181-1188.
34. Soenen SJH, Himmelreich U, Nuytten N, De Cuyper M. 2011. Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling. Biomaterials 32: 195-205.
35. 4 nanoparticles. Biomed. Mater. Res. A 80: 333-341.
36. Szalay B, Kováčiková Z, Brózik M, Pándics T, Tátrai E. 2008. Effects of iron oxide nanoparticles on pulmonary morphology, redox system, production of immunglobulins and chemokines in rats: in vivo and in vitro studies. Central Eur. J. Occup. Environ. Med. 14(2): 149-164.
37. Warheit DB, Sayes CM, Reed KL, Swain KA. 2008. Health effects related to nanoparticle exposures: environmental, health and safety considerations for assessing hazards and risks. Pharmacol. Ther. 120: 35-42.
38. Ying E, Hwang H. 2010. In vitro evaluation of the cytotoxicity of iron oxide nanoparticles with different coatings and different sizes in A3 human T lymphocytes. Sci. Total. Environ. 408: 4475-4481.
39. Yoshida R, Kitamura D, Maenosono S. 2009. Mutagenicity of water-soluble ZnO nanoparticles in Ames test. J. Toxicol. Sci. 34: 119-122.
40. Zhang Y, Kohler N, Zhang M. 2002. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 23(7): 1553-1561.